Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Intermittent Cottonseed Oil Consumption

University of Georgia · with Cotton Incorporated · NCT07246408

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 25–75 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
75
US sites recruiting
1
Study start
January 16, 2026
Record last updated
September 9, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Cardiovascular disease risk factors, including higher BMIs and poor cholesterol profiles, are on the rise and contribute to the United States' growing disease burden. Cottonseed oil (CSO) is found readily in the food supply, and the investigator's previous studies have demonstrated that incorporating CSO into the diet is sufficient to improve fasting and postprandial blood lipids and other markers of chronic disease risk in both healthy and at-risk populations. This study aims to examine the impact of intermittent CSO consumption at different doses (consumed three times per week (3x/wk)) on changes in fasting and postprandial lipid metabolism/blood lipids and markers of chronic disease risk.

The specific aims are: *Examine the impact of intermittent CSO consumption (3x/week) at two different doses on fasting and postprandial lipids. *Examine the impact of intermittent CSO consumption (3x/week) at two different doses on other markers of chronic disease risk.

Participants will be asked to

*Consume provided meal replacement shakes and snacks 3 times per week for 56 days. *Attend three bi-weekly (every other week) short visits for fasting blood draws, body measurements, and collection of the next two weeks' study materials. *Attend two longer (5.5h) testing visits, which include eating a standardized breakfast meal and having blood drawn periodically before and after breakfast.

Researchers will compare CSO-30, CSO-20, and Control groups (receiving no oil) to see if intermittent CSO consumption imparts the same health benefits as previously shown with daily doses of CSO.

Being studied: CSO-30; CSO-20; Control

Conditions: Dyslipidemia; Overweight and Obesity; Nutrition, Healthy

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • 25-75 year-old men and women at increased risk for cardiovascular disease. Increased risk for cardiovascular disease will be defined by either elevated cholesterol profiles -or- overweight/obesity.
  • Elevated cholesterol profiles will be defined as:
  • "Borderline High" and/or "at risk" in two of more of the following variables (total cholesterol: 180-239 mg/dL, LDL cholesterol 110-159 mg/dL, triglycerides 130-199 mg/dL) --or--
  • "High" in total cholesterol (240 mg/dL and higher), LDL (160 mg/dL or higher), or triglycerides (between 200-350 mg/dL).

Exclusion Criteria

  • Probable familial hypercholesterolemia, defined by: total cholesterol greater than 290 mg/dL or LDL levels greater than 190 mg/dL plus a family history of myocardial infarction (MI) before 50 years of age in a 2nd-degree relative or below age 60 in a 1st-degree relative.
  • Women on hormone replacement therapy less than 2 years.
  • Women who are pregnant or nursing/breastfeeding
  • individuals who regularly exercise more than 3h/w
  • weight gain or loss of more than 5% body weight in the past 3 months
  • plans to begin a weight loss/exercise regimen during the trial
  • history of medical or surgical events that could affect digestion or swallowing
  • gastrointestinal surgeries, conditions, or disorders
  • any chronic diseases (including moderate to severe asthma, chronic lung disease, and kidney disease),
  • metabolic disease
  • atherosclerosis
  • previous MI or stroke
  • cancer
  • fasting blood glucose levels greater than 126 mg/dL
  • blood pressure greater than 180/120 mmHg
  • medication use affecting digestion, absorption, or metabolism (e.g. thyroid meds), lipid-lowering medications, medications for diabetes, steroid/hormone therapies, or current antibiotic cycles
  • medically prescribed or special diets
  • Food allergies (specific to the foods in the study, including soy, dairy, gluten, Yellow No. 5, cottonseed oil, palm oil, and coconut oil)
  • fish oil supplements
  • excessive alcohol use (greater than 3 drinks/day for men; greater than 2 drinks/day for women)
  • tobacco or nicotine use
  • underweight BMI (\<18.5 kg/m²)

Recruiting US locations

  • University of Georgia

    Athens, GA 30602

    Site contact: Jamie A Cooper, PhD · 706-542-4378 · jamie.cooper@uga.edu

Study contacts (from the official record)

  • Jamie Cooper, PhD · 706-542-4378 · jamie.cooper@uga.edu
All weight loss studies in Georgia →
Intermittent Cottonseed Oil Consumption (NCT07246408) | Bored Studies